The Moses H. Cone Regional Cancer Center

Greensboro, North Carolina 27403

0 studies enrolling now · 2 studies all time

What they study most

Breast Neoplasm, Metastatic Breast Cancer

Studies at this site

• Trial of Dasatinib Plus Ixabepilone in 2nd or 3rd Line Metastatic Breast Cancer — Completed
• Tesetaxel as First-line Therapy for Metastatic Breast Cancer — Status unconfirmed